Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2

06.01.2023

Englisch

9783031189029

Springer International Publishing

Nein

Siguna Mueller

439

Gebundene Ausgabe

A Multidisciplinary Perspective

Siguna Mueller spent the first 20 years of her academic career in mathematics (M.S. in Mathematics and Statistics and Ph.D. in Mathematics, University of Klagenfurt, Austria, both summa cum laude). She was among the first women in Austria to receive the Habilitation in Discrete Mathematics and Cryptography (2002). The following 15 years she spent as a Research Associate at the Centre for Information Security and Cryptography Research, University of Calgary, and as an Assistant Professor at the University of Wyoming. A lifelong passion for biology and medicine eventually triggered her decision to radically expand her field of expertise. Consequently, she earned her second Ph.D. (Biomedical Sciences) in 2014 at the University of Wyoming (with a GPA of 4.0). Since then she has been utilizing her experience in the theoretical fields to help advance a broader appreciation and comprehension of phenomena and challenges arising in the biological and life science domains. For almost ten years, she has been warning of new Biosafety and Public Health dangers, but for years was ignored. Only recently, her concerns about new safety/security challenges in synthetic biology have been supported by others, and she has become one of the leaders in the new field of cyberbiosecurity. Her interests and curiosities are not limited to the above-mentioned disciplines as she finds great excitement in physics, theology, philosophy, ethics, spirituality, and the complexity and fascination of nature altogether. As such, it has been natural for her, employing her multi-disciplinary experience, to appraise the new Covid-19 vaccines, through rigorous, balanced, and scientific logic.

Vaccines, RNA Vaccines, COVID19, mRNA Vaccines, Public Health, Pharmacovigilance, SARS-CoV-2, Corona Virus, Vaccine Safety, Immune Response, Antibody Response, Vaccine Effectiveness

PSG - Mikrobiologie (nicht-medizinisch) MKFM - Mikrobiologie und Virologie TCB - Biotechnologie

235 mm

15.5 cm